SMS Pharma gains 18% on U.S FDA nod for reformulated Ranitidine of associate firm
SMS Pharma shares closed 17.74% higher at ₹322.60 apiece on the BSE
26 Nov 16:38 · The Hindu
last updated on 27 Nov 06:54